Biofrontera Inc.: A Dermatology Company Scaling with Momentum
April 8, 2026
INmune Bio, Inc. Announces Poster Presentation and Plenary Talk at the Alzheimer’s Association International Conference 2021
July 19, 2021
Related Post
-
-
Quantum-Si Announces First Customer Samples Tested on the Proteus(TM) Prototype System
April 8, 2026
-
Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5-Supported Clinical Activities
April 8, 2026
-
MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy
April 8, 2026